Atrial fibrillation and non-ischaemic cardiomyopathy in the peripartum period

被引:1
|
作者
Harper, A. [1 ]
Gerth, A. [2 ]
Marsh, C. [3 ]
Park, C. [4 ]
机构
[1] Bristol Royal Hosp Children, Dept Paediat Intens Care, Bristol, England
[2] Addenbrookes Hosp, Cambridge, England
[3] Royal United Hosp, Dept Anaesthesia, Bath, England
[4] Royal United Hosp, Dept Obstet, Bath, England
关键词
cardiac morbidity; pre-operative factors; neuraxial anaesthesia; cardiovascular effects; pregnancy; haemodynamic changes; Tachydysrhythmias; treatment;
D O I
10.1002/anr3.12078
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A 31-year-old primiparous woman with a history of bigeminy as a teenager developed atrial fibrillation with rapid ventricular response during elective caesarean section. Initial postoperative medical management was undertaken on the maternal high dependency unit and involved the administration of beta-blockers and digoxin. On postoperative day 1 the patient was transferred to the coronary care unit where she subsequently required synchronised direct current cardioversion to restore sinus rhythm. The patient remained on the coronary care unit for 5 days before discharge. Magnetic resonance imaging undertaken 6 weeks postpartum showed non-ischaemic cardiomyopathy. In this report, we discuss tachycardia-induced and peripartum cardiomyopathies, along with their potential underlying pathologies, incidence and associated morbidity. We describe potential pharmacological therapies including beta-blockers and angiotensin-converting enzyme inhibitors, as well as the implications of such medications for breastfeeding mothers. Patients presenting with palpitations in the antenatal period should receive prompt investigation including electrocardiography with ambulatory monitoring considered for those with persistent symptoms. Anyone with a proven cardiac arrhythmia should undergo echocardiography. This report illustrates the importance of the investigation of the symptoms of arrhythmia during pregnancy and emphasises the role of multidisciplinary working in the management of obstetric patients with complex medical comorbidity.
引用
收藏
页码:152 / 155
页数:4
相关论文
共 50 条
  • [21] Ischaemic vs non-ischaemic dilated cardiomyopathy: The value of nuclear cardiology techniques
    Federico Caobelli
    Frank M. Bengel
    Journal of Nuclear Cardiology, 2015, 22 : 971 - 974
  • [22] Exercise stress echocardiography differentiates ischaemic from non-ischaemic dilated cardiomyopathy
    Monserrat, L
    Peteiro, J
    Calviño, R
    Vazquez, JM
    Vazquez, E
    Perez, R
    Salgado, J
    Castro-Beiras, A
    EUROPEAN HEART JOURNAL, 2002, 23 : 549 - 549
  • [23] Impact of single atrial fibrillation catheter ablation onimplantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies
    Kosiuk, Jedrzej
    Nedios, Sotirios
    Darma, Angeliki
    Rolf, Sascha
    Richter, Sergio
    Arya, Arash
    Piorkowski, Christopher
    Gaspar, Thomas
    Sommer, Philipp
    Husser, Daniela
    Hindricks, Gerhard
    Bollmann, Andreas
    EUROPACE, 2014, 16 (09): : 1322 - 1326
  • [24] Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?
    de Groot, Joris R.
    NETHERLANDS HEART JOURNAL, 2023, 31 (3) : 87 - 88
  • [27] Implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy: a need or not?
    Joris R. de Groot
    Netherlands Heart Journal, 2023, 31 : 87 - 88
  • [28] GENDER DIFFERENCE AND ARRHYTHMIC RISK IN PATIENTS WITH NON-ISCHAEMIC CARDIOMYOPATHY
    Chung, Irene Kwai-Kuen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 614 - 614
  • [29] Role of implantable cardioverter defibrillators in non-ischaemic dilated cardiomyopathy
    Scott, Paul A.
    Roberts, Paul R.
    POSTGRADUATE MEDICAL JOURNAL, 2010, 86 (1012) : 116 - 122